Medical diagnosis is a field that doesn’t want to be left behind as more technology takes over health care — and rightly so. Arriving at a correct diagnosis faster can spell the difference between a life lost and a life saved. To wit, a novel method has just been approved by the U.S Food and Drug Administration (FDA) that allows faster allergy diagnosis using just a single drop of blood.
The test was developed five years ago by the Swiss Federal Institute of Technology in Lausanne (EPFL). An EPFL spin-off called Abionic, which took over the development of this method in 2010, created the abioSCOPE platform. This test requires single-use capsules, fed to a portable testing device currently capable of detecting four common allergies: dogs, cats, and pollens from common grasses and trees.
Already certified for use in Europe, the abioSCOPE allergy test is expected to enter the U.S. market in 2018.
Futurism Readers: Find out how much you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.